Navigate With Confidence

Bionavigen is a biopharmaceutical navigation company specializing in consulting for the discovery, preclinical development, translational, and regulatory sciences as well as early development of new drugs through smart acquisition.

Drug hunting

ADC Drug Development

Immuno-oncology

Discovery

preclinical Development

clinical Development

CMC

Translational Sciences

Regulatory Sciences

Why Bionavigen?

Bionavigen offers real world drug development experience-based consulting services for biologics including:

Antibodies
Peptides
Recombinant Proteins
Bispecifics
Antibody Drug Conjugates (ADC)
Oncolytic Virus (gene editing and gene delivery)

Viral
Cell
Gene Therapy
Small Molecule Pharmaceuticals
Therapeutic Peptides
Medical Devices

Bionavigen Advantage:

A team of virtual full drug developers (preclinical, clinical and regulatory experts)
Actively engaged in acquisition of clinical stage biologics and small molecule drugs from pharmaceutical companies supported by funds from VC investment firms
Support from early VC funding to early proof-of-concept clinical trials

Bionavigen Drug Hunting Services:

Navigation of the current and future pipeline of the top ten biopharmaceutical companies
Smart due diligence of potential out-licensing candidates using the latest scientific knowledge and soft intelligence
Special emphasis on promising drug candidates in new disease indications or through new innovative combinations
Investor backed drug acquisition and development through proof-of-concept